8-KAccepted Sep 29, 4:15 PM ET
Apimeds Pharmaceuticals Announces MindWave Blockchain Service Agreements
Accepted (ET)
4:15 PM
Sep 29, 2026
Filed
Sep 29, 2026
Documents
13
Size
253.8 KB
Summary
Apimeds Pharmaceuticals Announces MindWave Blockchain Service Agreements
What Happened
- Apimeds Pharmaceuticals US, Inc. (APUS) filed an 8-K (Sept. 29, 2026) reporting that its wholly owned subsidiary, MindWave Innovations Inc., announced two separate 12‑month technology services agreements.
- On Sept. 24, 2026 MindWave agreed with AQUAE Holdings Pte. Ltd. to deploy MindChain as the blockchain infrastructure for AQUAEChain, a platform for issuance, verification, transfer and retirement of ALCI Credits. Compensation includes software/technology service fees and an allocation of ALCI Credits issued on the network.
- On Sept. 29, 2026 MindWave agreed with Flash Sports & Media Holdings, Inc. (FLZH) to deploy and operate a dedicated subnet on MindChain’s Layer‑2 infrastructure for FlashChain (for tracking digital broadcasting rights, video assets and match ticket inventory) and to develop related integration and smart contract software. Compensation includes FLZH common shares and an allocation of FLASH TOKEN.
Key Details
- Counterparties: AQUAE Holdings Pte. Ltd. (Singapore) and Flash Sports & Media Holdings, Inc. (FLZH).
- Agreement term: each is a 12‑month Software Development and Technology Services Agreement.
- Consideration: cash/technology service fees and token allocations (ALCI Credits, FLASH TOKEN); FLZH shares are included as part of FlashChain consideration.
- MindWave is a wholly owned subsidiary of Apimeds (APUS); announcements were made via MindWave press releases in late Sept. 2026.
Why It Matters
- These deals could generate near‑term software development and technology service revenue for Apimeds’ subsidiary and provide equity and token‑based consideration that could affect future value if realized.
- The filings emphasize forward‑looking risks (development timelines, acceptance testing, token/equity valuation, integration and regulatory uncertainty). Investors should note the consideration includes digital assets and shares, whose value and liquidity are uncertain and subject to technical and regulatory risks.